董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Miriam Haran Independent Director 76 13.26万美元 5.33 2026-03-11
Avisar Paz Independent Director 69 10.33万美元 2.54 2026-03-11
Aviad Kaufman Director 55 9.68万美元 未持股 2026-03-11
Sagi Kabla Director 49 11.09万美元 未持股 2026-03-11
Lior Reitblatt Independent Director 68 11.74万美元 6.21 2026-03-11
Reem Aminoach Independent Director 64 8.24万美元 6.21 2026-03-11
Tzipi Ozer Armon Independent Director 60 9.38万美元 2.43 2026-03-11
Shalom Shlomo Independent Director 48 7.83万美元 未持股 2026-03-11
Michal Silverberg Independent Director 49 未披露 未持股 2026-03-11
Dafna Gruber Independent Director 60 未披露 未持股 2026-03-11
Gadi Lesin Independent Director 58 11.28万美元 未持股 2026-03-11
Dafna Gruber Independent Director 61 12.08万美元 未持股 2026-03-11
Yoav Doppelt Director and Executive Chairman of the Board 57 未披露 171.30 2026-03-11
Michal Silverberg Independent Director 49 9.77万美元 未持股 2026-03-11

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Amir Meshulam Senior Vice President, Global Internal Auditor 49 未披露 39.03 2026-03-11
Anantha N. Desikan Chief Innovation and Technology Officer and Executive Vice President 58 未披露 85.88 2026-03-11
Ilana Fahima Chief People Officer and Executive Vice President 60 未披露 130.52 2026-03-11
Lilach Geva Harel Deputy Chief Executive Officer 49 未披露 130.52 2026-03-11
Miri Mishor Executive Vice President, Global Information Technology 62 未披露 87.84 2026-03-11
Ilan Barkai Head of Israel Phosphate Operation and President, ICL Potash Division 57 未披露 15.76 2026-03-11
Maya Grinfeld Senior Vice President, ICL Marketing and Communication 50 未披露 未持股 2026-03-11
Nir Ilani President, ICL Growing Solutions Division 49 未披露 未持股 2026-03-11
Nadav Turner President, ICL Phosphate Specialty Solutions Division 50 未披露 97.33 2026-03-11
Uri Perelman Chief Corporate Business Development Officer and Executive Vice President 45 未披露 74.97 2026-03-11
Yaniv Kabalek President, ICL Industrial Products Division 51 未披露 76.75 2026-03-11
Elad Aharonson Chief Executive Officer and President 52 未披露 265.79 2026-03-11
Yoav Doppelt Director and Executive Chairman of the Board 57 未披露 171.30 2026-03-11
Aviram Lahav Chief Financial Officer 67 未披露 157.82 2026-03-11

董事简历

中英对照 |  中文 |  英文
Miriam Haran

Miriam Haran,Haran博士从2009年9月开始一直担任董事。Haran博士担任以色列环境部(Israel's Ministry of the Environment)的处长。Haran博士担任阿挪学术学院(Ono Academic College)的环境管理学工商管理硕士课程的负责人,担任Ashkelon-Eilat Pipeline Ltd.的顾问,并从2008年至2012年担任该公司的环境服务部成员。Haran博士还担任M.A.I(回收电气与电子废料)的董事与消费者委员会主席。Haran博士在布兰迪斯大学(Brandeis University)获得有机化学博士学位,并在耶路撒冷希伯来大学(Hebrew University of Jerusalem)获得自然科学理学学士学位。


Miriam Haran has been involved in environmental management and safety issues for over forty years in vario key positions. Dr. Haran is currently serving as chair of Israel Resce Efficiency Center – a knowledge and consulting center for reducing the environmental impact of indtry by streamlining raw materials, energy, water, etc. She is chair of the itz Center for Stainable Development and a board member of M.A.I – a major Israeli recycling company of electrical and electronic waste as ll as the Chair of the Public Safety Committee in the Prime Minister's Office. Dr. Haran previoly served as Director General, Deputy Director General and Chief Scientist of Israel's Ministry of Environmental Protection, as ll as the Head of Ono Academic College's MBA Program in Environmental Management. Dr. Haran has served in numero scientific, corporate, and public organizations. She was Chair of the Israel Consumer Council, Environmental Consultant, Board Member of The Environmental Services Company Ltd. (ESC), Board Member of BGN Technologies Ltd., and Member of the General Assembly of the Jeralem Institute for Israel Studies. Significantly, Dr. Haran's research has directly contributed to fields pertinent to ICL's biness. Her research work at A.Y. Laboratories and Unikoor Biotechnology as a Researcher involved chemical research on bromine compounds and biocides, directly relating to the materials ICL has been producing for years. Additionally, Dr. Haran's academic endeavors during her doctoral and postdoctoral studies at the Hebrew University of Jeralem and at Rutgers University in Newark, New Jersey, consistently foced on chemical research. Dr. Haran served as an external director of ICL beten 2010 2018. Dr. Haran holds a B.Sc. degree in Natural Sciences from the Hebrew University of Jeralem and a PhD in Organic Chemistry from Brandeis University.
Miriam Haran,Haran博士从2009年9月开始一直担任董事。Haran博士担任以色列环境部(Israel's Ministry of the Environment)的处长。Haran博士担任阿挪学术学院(Ono Academic College)的环境管理学工商管理硕士课程的负责人,担任Ashkelon-Eilat Pipeline Ltd.的顾问,并从2008年至2012年担任该公司的环境服务部成员。Haran博士还担任M.A.I(回收电气与电子废料)的董事与消费者委员会主席。Haran博士在布兰迪斯大学(Brandeis University)获得有机化学博士学位,并在耶路撒冷希伯来大学(Hebrew University of Jerusalem)获得自然科学理学学士学位。
Miriam Haran has been involved in environmental management and safety issues for over forty years in vario key positions. Dr. Haran is currently serving as chair of Israel Resce Efficiency Center – a knowledge and consulting center for reducing the environmental impact of indtry by streamlining raw materials, energy, water, etc. She is chair of the itz Center for Stainable Development and a board member of M.A.I – a major Israeli recycling company of electrical and electronic waste as ll as the Chair of the Public Safety Committee in the Prime Minister's Office. Dr. Haran previoly served as Director General, Deputy Director General and Chief Scientist of Israel's Ministry of Environmental Protection, as ll as the Head of Ono Academic College's MBA Program in Environmental Management. Dr. Haran has served in numero scientific, corporate, and public organizations. She was Chair of the Israel Consumer Council, Environmental Consultant, Board Member of The Environmental Services Company Ltd. (ESC), Board Member of BGN Technologies Ltd., and Member of the General Assembly of the Jeralem Institute for Israel Studies. Significantly, Dr. Haran's research has directly contributed to fields pertinent to ICL's biness. Her research work at A.Y. Laboratories and Unikoor Biotechnology as a Researcher involved chemical research on bromine compounds and biocides, directly relating to the materials ICL has been producing for years. Additionally, Dr. Haran's academic endeavors during her doctoral and postdoctoral studies at the Hebrew University of Jeralem and at Rutgers University in Newark, New Jersey, consistently foced on chemical research. Dr. Haran served as an external director of ICL beten 2010 2018. Dr. Haran holds a B.Sc. degree in Natural Sciences from the Hebrew University of Jeralem and a PhD in Organic Chemistry from Brandeis University.
Avisar Paz

Avisar Paz,Paz先生从2001年4月开始一直担任董事。Paz先生担任以色列控股集团(Israel Corporation)的首席财务官,并担任多个子公司的董事。在这之前,Paz先生担任另一家公司的首席财务官兼财务总管。他担任石油精炼公司(Oil Refineries Ltd.)的董事。Paz先生在特拉维夫大学(Tel Aviv University)获得经济学与会计学的文学学士学位,并是以色列的一位注册会计师。


Avisar Paz served as the Chairman of the Board of Directors of OPC Energy Ltd. until January 3, 2021. Previoly, Mr. Paz served as the Chief Executive Officer of Israel Corp. and prior to that, as the Chief Financial Officer of Israel Corp. Mr. Paz received a BA degree in Economics and Accounting from Tel Aviv University and is a certified public accountant in Israel (CPA).
Avisar Paz,Paz先生从2001年4月开始一直担任董事。Paz先生担任以色列控股集团(Israel Corporation)的首席财务官,并担任多个子公司的董事。在这之前,Paz先生担任另一家公司的首席财务官兼财务总管。他担任石油精炼公司(Oil Refineries Ltd.)的董事。Paz先生在特拉维夫大学(Tel Aviv University)获得经济学与会计学的文学学士学位,并是以色列的一位注册会计师。
Avisar Paz served as the Chairman of the Board of Directors of OPC Energy Ltd. until January 3, 2021. Previoly, Mr. Paz served as the Chief Executive Officer of Israel Corp. and prior to that, as the Chief Financial Officer of Israel Corp. Mr. Paz received a BA degree in Economics and Accounting from Tel Aviv University and is a certified public accountant in Israel (CPA).
Aviad Kaufman

Aviad Kaufman,Kaufman先生从2014年3月开始担任当前职位。他担任Quantum Pacific UK LLP的首席财务官,并担任以色列控股集团(Israel Corporation)、Lynav Holdings Ltd.、Lynav Maritime Ltd.与Marabel II Ltd.的董事。Kafuman先生是一位会计师,在希伯来大学(Hebrew University)获得经济学与会计学的文学学士学位,并在特拉维夫大学(Tel Aviv University)获得主修财务学的工商管理硕士学位。


Aviad Kaufman is the Chief Executive Officer of One Globe Business Advisory Ltd, the chairman of IC, and serves on the board of directors of ICL Group Ltd., OPC and other private companies, each of which may be associated with the same ultimate beneficiary, Mr. Idan Ofer. From 2017 until July 2021, Mr. Kaufman served as the Chief Executive Officer of Quantum Pacific (UK) LLP and from 2008 until 2017 as Chief Financial Officer of Quantum Pacific (UK) LLP (and its predecessor Quantum Pacific Advisory Limited). From 2002 until 2007, Mr. Kaufman fulfilled different senior corporate finance roles at Amdocs Ltd. Previously, Mr. Kaufman held various consultancy positions with KPMG. Mr. Kaufman is a certified public accountant and holds a Bachelor's degree in Accounting and Economics from the Hebrew University in Jerusalem (with distinction), and a Master of Business Administration in Finance from Tel Aviv University.
Aviad Kaufman,Kaufman先生从2014年3月开始担任当前职位。他担任Quantum Pacific UK LLP的首席财务官,并担任以色列控股集团(Israel Corporation)、Lynav Holdings Ltd.、Lynav Maritime Ltd.与Marabel II Ltd.的董事。Kafuman先生是一位会计师,在希伯来大学(Hebrew University)获得经济学与会计学的文学学士学位,并在特拉维夫大学(Tel Aviv University)获得主修财务学的工商管理硕士学位。
Aviad Kaufman is the Chief Executive Officer of One Globe Business Advisory Ltd, the chairman of IC, and serves on the board of directors of ICL Group Ltd., OPC and other private companies, each of which may be associated with the same ultimate beneficiary, Mr. Idan Ofer. From 2017 until July 2021, Mr. Kaufman served as the Chief Executive Officer of Quantum Pacific (UK) LLP and from 2008 until 2017 as Chief Financial Officer of Quantum Pacific (UK) LLP (and its predecessor Quantum Pacific Advisory Limited). From 2002 until 2007, Mr. Kaufman fulfilled different senior corporate finance roles at Amdocs Ltd. Previously, Mr. Kaufman held various consultancy positions with KPMG. Mr. Kaufman is a certified public accountant and holds a Bachelor's degree in Accounting and Economics from the Hebrew University in Jerusalem (with distinction), and a Master of Business Administration in Finance from Tel Aviv University.
Sagi Kabla

Sagi Kabla,他于2016年2月8日被任命为董事。他是Israel Corporation的首席财务官(2015年12月以来)。他担任Bazan Group的董事,此前曾担任Israel Corporation的高级主管,负责业务发展、战略和IR。加入Israel Corporation之前,他曾担任KPMG Corporate Finance的多种职务。他是以色列注册会计师,并持有Bar-Ilan University的会计和经济学学士学位,以及the College of Management Studies的财务工商管理硕士学位。


Sagi Kabla has served as Chief Financial Officer of Israel Corp. since December 2015. Mr. Kabla previoly served as a director of Oil Refineries Ltd., Tor Semiconductor Ltd., and Prodalim Investments Ltd., and as Senior Executive for Biness Development, Strategy, and Investor Relations at Israel Corp. Prior to joining Israel Corp., Mr. Kabla held vario managerial positions at KPMG Corporate Finance and M&A. Mr. Kabla holds an MBA degree in Finance from COMAS and a B.A. degree in Economics and Accounting from Bar Ilan University and is a certified public accountant in Israel.
Sagi Kabla,他于2016年2月8日被任命为董事。他是Israel Corporation的首席财务官(2015年12月以来)。他担任Bazan Group的董事,此前曾担任Israel Corporation的高级主管,负责业务发展、战略和IR。加入Israel Corporation之前,他曾担任KPMG Corporate Finance的多种职务。他是以色列注册会计师,并持有Bar-Ilan University的会计和经济学学士学位,以及the College of Management Studies的财务工商管理硕士学位。
Sagi Kabla has served as Chief Financial Officer of Israel Corp. since December 2015. Mr. Kabla previoly served as a director of Oil Refineries Ltd., Tor Semiconductor Ltd., and Prodalim Investments Ltd., and as Senior Executive for Biness Development, Strategy, and Investor Relations at Israel Corp. Prior to joining Israel Corp., Mr. Kabla held vario managerial positions at KPMG Corporate Finance and M&A. Mr. Kabla holds an MBA degree in Finance from COMAS and a B.A. degree in Economics and Accounting from Bar Ilan University and is a certified public accountant in Israel.
Lior Reitblatt

Lior Reitblatt是一名注册会计师,并持有特拉维夫大学会计和经济学学士学位和加州大学伯克利分校工商管理硕士学位。直到最近,Reitblatt先生担任Super-Pharm Israel Ltd.的首席执行官兼董事会主席。Reitblatt先生此前还曾担任Life Style Ltd.的董事会主席和Office Depot Israel Ltd.的董事会成员。


Lior Reitblatt served as Chief Executive Officer and Chairman of the Board of Super Pharm (Israel) Ltd. for 28 years. During his tenure, he was extensively involved in the management and marketing of medications and chemical products for medical preparations, cosmetics, and toiletries, with a foc on the selection and sorting processes of private label products and products from the chain's central laboratory. His leadership at Super Pharm also included overseeing vario strategic initiatives in these areas, solidifying his expertise in both the pharmaceutical and retail sectors. In addition, Mr. Reitblatt has also previoly served, among other positions, as Chairman of the Board of LifeStyle Ltd. and member of the board of Office Depot Israel Ltd. For the past eight years, Mr. Reitblatt has been serving as the Chairman of the Advisory Board of Amorphical, a company foced on the development of chemical products with an amorpho structure. In this role, he has played a key part in the development of new products in the field of chemical and pharmaceutical innovation, further enhancing his managerial experience in these indtries. Mr. Reitblatt is a certified public accountant and holds a BA degree in Accounting and Economics from Tel Aviv University and an MBA degree from the University of California, Berkeley.
Lior Reitblatt是一名注册会计师,并持有特拉维夫大学会计和经济学学士学位和加州大学伯克利分校工商管理硕士学位。直到最近,Reitblatt先生担任Super-Pharm Israel Ltd.的首席执行官兼董事会主席。Reitblatt先生此前还曾担任Life Style Ltd.的董事会主席和Office Depot Israel Ltd.的董事会成员。
Lior Reitblatt served as Chief Executive Officer and Chairman of the Board of Super Pharm (Israel) Ltd. for 28 years. During his tenure, he was extensively involved in the management and marketing of medications and chemical products for medical preparations, cosmetics, and toiletries, with a foc on the selection and sorting processes of private label products and products from the chain's central laboratory. His leadership at Super Pharm also included overseeing vario strategic initiatives in these areas, solidifying his expertise in both the pharmaceutical and retail sectors. In addition, Mr. Reitblatt has also previoly served, among other positions, as Chairman of the Board of LifeStyle Ltd. and member of the board of Office Depot Israel Ltd. For the past eight years, Mr. Reitblatt has been serving as the Chairman of the Advisory Board of Amorphical, a company foced on the development of chemical products with an amorpho structure. In this role, he has played a key part in the development of new products in the field of chemical and pharmaceutical innovation, further enhancing his managerial experience in these indtries. Mr. Reitblatt is a certified public accountant and holds a BA degree in Accounting and Economics from Tel Aviv University and an MBA degree from the University of California, Berkeley.
Reem Aminoach

Reem Aminoach是一名注册会计师,并持有特拉维夫大学会计和经济学学士学位,学术荣誉,院长荣誉榜和工商管理硕士学位。直到最近,Aminoach先生担任会计师事务所Shtaimetz Aminoach&Co.的创始合伙人。Aminoach准将在服役期间曾担任以色列国防军总参谋部论坛成员、国防部预算司司长、以色列国防军参谋长财务顾问和以色列国防军预算司司长。Aminoach先生曾担任Ofer Investments Ltd.的董事,并担任以色列公司集团(Israel Corporation Group)的Zim Ltd.的董事兼审计委员会主席。Aminoach先生还担任Hadassah Medical Center的董事会成员。


Reem Aminoach serves as a director of the Institute for National Security Studies. Until recently, Mr. Aminoach served as a director of Israel Aerospace Indtries and as the founding partner of the accounting firm Shtainmetz Aminoach & Co. In his military service, Mr. Aminoach, a brigadier general, served as a member of the General Staff Forum of the IDF, Head of Budgets at the Ministry of Defense, Financial Advisor to the IDF Chief of Staff and Head of the IDF Budget Division. Previoly, Mr. Aminoach served as director at Ofer Investments Ltd. and as director and Chairman of the Audit Committee at Zim Ltd., of the Israel Corp. group. Mr. Aminoach also served as a member of the Board of Governors of Hadassah Medical Center. Mr. Aminoach is a certified public accountant, and holds a BA degree in Accounting and Economics, Tel Aviv University (academic honors, Dean's honor list) and MBA degree in Biness Administration, Tel Aviv University.
Reem Aminoach是一名注册会计师,并持有特拉维夫大学会计和经济学学士学位,学术荣誉,院长荣誉榜和工商管理硕士学位。直到最近,Aminoach先生担任会计师事务所Shtaimetz Aminoach&Co.的创始合伙人。Aminoach准将在服役期间曾担任以色列国防军总参谋部论坛成员、国防部预算司司长、以色列国防军参谋长财务顾问和以色列国防军预算司司长。Aminoach先生曾担任Ofer Investments Ltd.的董事,并担任以色列公司集团(Israel Corporation Group)的Zim Ltd.的董事兼审计委员会主席。Aminoach先生还担任Hadassah Medical Center的董事会成员。
Reem Aminoach serves as a director of the Institute for National Security Studies. Until recently, Mr. Aminoach served as a director of Israel Aerospace Indtries and as the founding partner of the accounting firm Shtainmetz Aminoach & Co. In his military service, Mr. Aminoach, a brigadier general, served as a member of the General Staff Forum of the IDF, Head of Budgets at the Ministry of Defense, Financial Advisor to the IDF Chief of Staff and Head of the IDF Budget Division. Previoly, Mr. Aminoach served as director at Ofer Investments Ltd. and as director and Chairman of the Audit Committee at Zim Ltd., of the Israel Corp. group. Mr. Aminoach also served as a member of the Board of Governors of Hadassah Medical Center. Mr. Aminoach is a certified public accountant, and holds a BA degree in Accounting and Economics, Tel Aviv University (academic honors, Dean's honor list) and MBA degree in Biness Administration, Tel Aviv University.
Tzipi Ozer Armon

Tzipi Ozer Armon自2012年5月加入Lumenis以来一直担任该公司的首席执行官。任职期间,Ozer-Armon女士管理Lumenis,通过全面的增长和盈利扭亏为盈,以及2014年在纳斯达克IPO。Ozer-Armon女士领导了Lumenis向私募股权公司的两个销售过程,2016年的估值为5.5亿美元,2020年的估值超过10亿美元。在加入Lumenis之前,Ozer-Armon女士领导Teva Pharmaceutical Industries Ltd.的日本市场活动。纳斯达克股票代码:TEVA,成交额超过8亿美元的业务。在此之前,Ozer-Armon女士曾担任SanDisk(纳斯达克市场代码:SNDK)销售与市场营销的高级副总裁。她也曾担任MSystems公司(NASDAQ:FLSH)的副总裁兼总经理,以及Comverse公司(NASDAQ:CMVT)的公司发展副总裁。Ozer-Armon&8217;s女士此前在总部位于英国伦敦的全球管理咨询公司Atkearney工作了四年。Ozer-Armon女士是Itamar MedicalLtd.,Strauss Group Ltd.,ICL Ltd.,Rambam Medtech,以色列国家技术创新局委员会和特拉维夫大学的董事。Ozer-Armon女士拥有以色列特拉维夫大学(Tel-Aviv University)经济学学士学位和金融与营销专业工商管理硕士学位。


Tzipi Ozer Armon serves as the Chief Executive Officer of Lumenis Ltd. Before joining Lumenis, she headed the Japanese market activities of Teva Pharmaceutical Indtries Ltd. and served as Senior Vice President of Sales and Marketing at SanDisk. Previoly, Ms. Ozer Armon also served as VP & General Manager at MSystems. In addition to ICL, Ms. Ozer Armon is a director at Check Point Software Technologies Ltd. Ms. Ozer Armon holds a BA degree, magna cum laude, in Economics, and an MBA degree in Finance and Marketing from Tel Aviv University, and she is an AMP graduate of the Harvard Biness School.
Tzipi Ozer Armon自2012年5月加入Lumenis以来一直担任该公司的首席执行官。任职期间,Ozer-Armon女士管理Lumenis,通过全面的增长和盈利扭亏为盈,以及2014年在纳斯达克IPO。Ozer-Armon女士领导了Lumenis向私募股权公司的两个销售过程,2016年的估值为5.5亿美元,2020年的估值超过10亿美元。在加入Lumenis之前,Ozer-Armon女士领导Teva Pharmaceutical Industries Ltd.的日本市场活动。纳斯达克股票代码:TEVA,成交额超过8亿美元的业务。在此之前,Ozer-Armon女士曾担任SanDisk(纳斯达克市场代码:SNDK)销售与市场营销的高级副总裁。她也曾担任MSystems公司(NASDAQ:FLSH)的副总裁兼总经理,以及Comverse公司(NASDAQ:CMVT)的公司发展副总裁。Ozer-Armon&8217;s女士此前在总部位于英国伦敦的全球管理咨询公司Atkearney工作了四年。Ozer-Armon女士是Itamar MedicalLtd.,Strauss Group Ltd.,ICL Ltd.,Rambam Medtech,以色列国家技术创新局委员会和特拉维夫大学的董事。Ozer-Armon女士拥有以色列特拉维夫大学(Tel-Aviv University)经济学学士学位和金融与营销专业工商管理硕士学位。
Tzipi Ozer Armon serves as the Chief Executive Officer of Lumenis Ltd. Before joining Lumenis, she headed the Japanese market activities of Teva Pharmaceutical Indtries Ltd. and served as Senior Vice President of Sales and Marketing at SanDisk. Previoly, Ms. Ozer Armon also served as VP & General Manager at MSystems. In addition to ICL, Ms. Ozer Armon is a director at Check Point Software Technologies Ltd. Ms. Ozer Armon holds a BA degree, magna cum laude, in Economics, and an MBA degree in Finance and Marketing from Tel Aviv University, and she is an AMP graduate of the Harvard Biness School.
Shalom Shlomo

Shalom Shlomo自2023年5月起担任Haim Avshalom研究所主席,并自2023年8月起担任以色列上市公司Ashdod Refinery Ltd.的董事。作为在私营部门任职的一部分,什洛莫先生向以色列能源、基础设施和电信公司等提供咨询服务。此外,什洛莫先生还在公共部门担任过多个高级职位,包括从2021年6月至2023年1月担任以色列内阁秘书。Shlomo先生拥有以色列法律和Biness学术中心法学法学学士学位。


Shalom Shlomo serves as the chairman of the Haim Avshalom Institute, since May 2023, and as a director of Ashdod Refinery Ltd., an Israeli public company, since Augt 2023. As part of his positions in the private sector, Mr. Shlomo provided consulting services to Israeli energy, infrastructure and telecommunications companies, among others. In addition, Mr. Shlomo served in vario senior positions in the public sector, including as the Israeli Cabinet Secretary from June 2021 until January 2023. Mr. Shlomo holds an LLB degree in law from the Israeli Academic Center for Law and Biness.
Shalom Shlomo自2023年5月起担任Haim Avshalom研究所主席,并自2023年8月起担任以色列上市公司Ashdod Refinery Ltd.的董事。作为在私营部门任职的一部分,什洛莫先生向以色列能源、基础设施和电信公司等提供咨询服务。此外,什洛莫先生还在公共部门担任过多个高级职位,包括从2021年6月至2023年1月担任以色列内阁秘书。Shlomo先生拥有以色列法律和Biness学术中心法学法学学士学位。
Shalom Shlomo serves as the chairman of the Haim Avshalom Institute, since May 2023, and as a director of Ashdod Refinery Ltd., an Israeli public company, since Augt 2023. As part of his positions in the private sector, Mr. Shlomo provided consulting services to Israeli energy, infrastructure and telecommunications companies, among others. In addition, Mr. Shlomo served in vario senior positions in the public sector, including as the Israeli Cabinet Secretary from June 2021 until January 2023. Mr. Shlomo holds an LLB degree in law from the Israeli Academic Center for Law and Biness.
Michal Silverberg

Michal Silverberg自2017年起担任诺华风险基金(“NVF”)的董事总经理。在加入NVF之前和从2014年起,Silverberg女士曾担任Takeda Ventures的高级合伙人,在此之前和从2007年起,Silverberg女士曾在诺和诺德担任越来越重要的职务,包括担任Biness开发和新产品商业化高级总监,并担任BioPharm领导团队的成员。自1998年以来,Silverberg女士在生命科学产业的多个领域任职,包括在以色列首席科学家办公室(孵化器计划)、风险投资(Ofer Brothers Hi Tech Investment Group)以及全球制药和生物技术公司任职,包括在以色列生物技术公司MGVS Ltd.的多个职位,以及在OSI Pharmaceuticals,Inc.担任biness开发职务。Silverberg女士目前在几家私营公司担任董事。Silverberg女士拥有以色列海法大学经济学和biness管理学士学位、以色列特拉维夫大学工商管理硕士学位和纽约哥伦比亚大学生物技术硕士学位。


Michal Silverberg has served as a Managing Director at the Novartis Venture Fund ("NVF") since 2017. Prior to joining NVF and from 2014, Ms. Silverberg served as a Senior Partner at Takeda Ventures and, prior to that and from 2007, Ms. Silverberg worked at Novo Nordisk in roles of increasing responsibility, including as Senior Director Biness Development and New Product Commercialization, serving as a member of the BioPharm leadership team. Since 1998, Ms. Silverberg has held positions in vario sectors of the life science indtry, including in the Office of the Chief Scientist of Israel (the incubator program), venture capital (Ofer Brothers Hi Tech investing group) and global pharmaceutical and biotech companies, including vario positions at MGVS Ltd., an Israeli biotech company, and at OSI Pharmaceuticals, Inc. in a biness development role. Ms. Silverberg currently serves as a director in several private companies. Ms. Silverberg holds a B.A. degree in economics and biness management from Haifa University, Israel, an M.B.A. degree from Tel Aviv University, Israel, and a MA degree in Biotechnology from Columbia University, New York.
Michal Silverberg自2017年起担任诺华风险基金(“NVF”)的董事总经理。在加入NVF之前和从2014年起,Silverberg女士曾担任Takeda Ventures的高级合伙人,在此之前和从2007年起,Silverberg女士曾在诺和诺德担任越来越重要的职务,包括担任Biness开发和新产品商业化高级总监,并担任BioPharm领导团队的成员。自1998年以来,Silverberg女士在生命科学产业的多个领域任职,包括在以色列首席科学家办公室(孵化器计划)、风险投资(Ofer Brothers Hi Tech Investment Group)以及全球制药和生物技术公司任职,包括在以色列生物技术公司MGVS Ltd.的多个职位,以及在OSI Pharmaceuticals,Inc.担任biness开发职务。Silverberg女士目前在几家私营公司担任董事。Silverberg女士拥有以色列海法大学经济学和biness管理学士学位、以色列特拉维夫大学工商管理硕士学位和纽约哥伦比亚大学生物技术硕士学位。
Michal Silverberg has served as a Managing Director at the Novartis Venture Fund ("NVF") since 2017. Prior to joining NVF and from 2014, Ms. Silverberg served as a Senior Partner at Takeda Ventures and, prior to that and from 2007, Ms. Silverberg worked at Novo Nordisk in roles of increasing responsibility, including as Senior Director Biness Development and New Product Commercialization, serving as a member of the BioPharm leadership team. Since 1998, Ms. Silverberg has held positions in vario sectors of the life science indtry, including in the Office of the Chief Scientist of Israel (the incubator program), venture capital (Ofer Brothers Hi Tech investing group) and global pharmaceutical and biotech companies, including vario positions at MGVS Ltd., an Israeli biotech company, and at OSI Pharmaceuticals, Inc. in a biness development role. Ms. Silverberg currently serves as a director in several private companies. Ms. Silverberg holds a B.A. degree in economics and biness management from Haifa University, Israel, an M.B.A. degree from Tel Aviv University, Israel, and a MA degree in Biotechnology from Columbia University, New York.
Dafna Gruber

Dafna Gruber目前担任均在纳斯达克上市的Check Point软件和Cellbrite DI Ltd.的外部董事,previoly曾在Nova Ltd.和TAT科技 Ltd.等多家公司担任独立董事。在2025年之前,Gruber女士一直担任精密灌溉解决方案公司Netafim Ltd.的首席财务官。在加入耐特菲姆之前,Gruber女士曾在多家公司担任首席财务官职务,包括2015年至2017年的Clal Indtries、2007年至2015年的Nice Systems Ltd.和1999年至2007年的Alvarion Ltd.。Gruber女士是一名注册会计师,拥有特拉维夫大学会计和经济学学士学位。


Dafna Gruber currently serves as an external director of Check Point Software Technologies Ltd. and Cellbrite DI Ltd, both traded on NASDAQ, and previoly served as an independent director at several companies including Nova Ltd. and TAT Technologies Ltd. Until 2025, Ms. Gruber served as the Chief Financial Officer of Netafim Ltd., a precision irrigation solutions company. Prior to joining Netafim Ms. Gruber held Chief Financial Officer positions in vario companies including Clal Indtries from 2015 to 2017, Nice Systems Ltd. from 2007 to 2015, and Alvarion Ltd. from 1999 to 2007. Ms. Gruber is a certified public accountant and holds a BA degree in Accounting and Economics from Tel Aviv University.
Dafna Gruber目前担任均在纳斯达克上市的Check Point软件和Cellbrite DI Ltd.的外部董事,previoly曾在Nova Ltd.和TAT科技 Ltd.等多家公司担任独立董事。在2025年之前,Gruber女士一直担任精密灌溉解决方案公司Netafim Ltd.的首席财务官。在加入耐特菲姆之前,Gruber女士曾在多家公司担任首席财务官职务,包括2015年至2017年的Clal Indtries、2007年至2015年的Nice Systems Ltd.和1999年至2007年的Alvarion Ltd.。Gruber女士是一名注册会计师,拥有特拉维夫大学会计和经济学学士学位。
Dafna Gruber currently serves as an external director of Check Point Software Technologies Ltd. and Cellbrite DI Ltd, both traded on NASDAQ, and previoly served as an independent director at several companies including Nova Ltd. and TAT Technologies Ltd. Until 2025, Ms. Gruber served as the Chief Financial Officer of Netafim Ltd., a precision irrigation solutions company. Prior to joining Netafim Ms. Gruber held Chief Financial Officer positions in vario companies including Clal Indtries from 2015 to 2017, Nice Systems Ltd. from 2007 to 2015, and Alvarion Ltd. from 1999 to 2007. Ms. Gruber is a certified public accountant and holds a BA degree in Accounting and Economics from Tel Aviv University.
Gadi Lesin

Gadi Lesin曾于2009年至2018年担任国际食品和饮料公司、以色列最大的食品公司Stras Group Ltd.(简称“Stras Group”)的总裁兼首席执行官。Lesin先生成功地带领Stras集团度过了经济、全球和社会剧烈变革的时期。在他的领导下,Stras集团加强了国际业务,股权价值翻了一倍多,利润大幅增长。Lesin先生目前担任Soglok Ltd.的董事以及Wonder Veggies的创始人和董事。此外,Lesin先生担任ORIAN SH.M的董事。Ltd.和作为Electra Consumer Products的外部董事,这两家公司都在TASE上市。Lesin先生拥有特拉维夫管理学院的BINES管理学士学位和本古里安大学的MBA学位。


Gadi Lesin served as President and CEO of Stras Group Ltd. ("Stras Group"), an international food and beverage company and the largest food company in Israel, from 2009 to 2018. Mr. Lesin successfully led the Stras Group through a time of intense economic, global and social change. Under his leadership, the Stras Group strengthened its international operations, more than doubled its equity value, and grew its profits significantly. Mr. Lesin currently serves as a director at Soglok Ltd. and a founder and director at Wonder Veggies. In addition, Mr. Lesin serves as a director of ORIAN SH.M. Ltd. and as an external director of Electra Consumer Products, both companies listed on the TASE. Mr. Lesin holds a BA degree in biness management from the Tel Aviv College of Management and an MBA degree from Ben Gurion University.
Gadi Lesin曾于2009年至2018年担任国际食品和饮料公司、以色列最大的食品公司Stras Group Ltd.(简称“Stras Group”)的总裁兼首席执行官。Lesin先生成功地带领Stras集团度过了经济、全球和社会剧烈变革的时期。在他的领导下,Stras集团加强了国际业务,股权价值翻了一倍多,利润大幅增长。Lesin先生目前担任Soglok Ltd.的董事以及Wonder Veggies的创始人和董事。此外,Lesin先生担任ORIAN SH.M的董事。Ltd.和作为Electra Consumer Products的外部董事,这两家公司都在TASE上市。Lesin先生拥有特拉维夫管理学院的BINES管理学士学位和本古里安大学的MBA学位。
Gadi Lesin served as President and CEO of Stras Group Ltd. ("Stras Group"), an international food and beverage company and the largest food company in Israel, from 2009 to 2018. Mr. Lesin successfully led the Stras Group through a time of intense economic, global and social change. Under his leadership, the Stras Group strengthened its international operations, more than doubled its equity value, and grew its profits significantly. Mr. Lesin currently serves as a director at Soglok Ltd. and a founder and director at Wonder Veggies. In addition, Mr. Lesin serves as a director of ORIAN SH.M. Ltd. and as an external director of Electra Consumer Products, both companies listed on the TASE. Mr. Lesin holds a BA degree in biness management from the Tel Aviv College of Management and an MBA degree from Ben Gurion University.
Dafna Gruber

Dafna Gruber拥有丰富的经验,曾在在纳斯达克和塔斯社交易的领先高科技公司担任首席财务官和高级执行管理层成员。从2019年2月到2021年2月,Gruber女士担任私营公司Aqua Security Ltd.的首席财务官。从2017年9月至2019年2月,Gruber女士担任Landa Corporation Ltd.的首席财务官,随后担任Landa Group的财务顾问。从2015年到2017年,Gruber女士担任私营公司Clal Industries Ltd.的首席财务官。从2007年到2015年,Gruber女士担任Nice Systems Ltd.的首席财务官,该公司是一家在纳斯达克和TASE上市的上市公司。作为高级管理团队的一员,格鲁伯女士曾是该公司战略与并购论坛的高级成员。在Nice工作期间,Gruber女士除其他外负责财务、运营、MIS和IT、法律和投资者关系。从1996年到2007年,Gruber女士隶属于Alvarion Ltd公司,该公司是一家在纳斯达克和TASE上市的上市公司,主要担任首席财务官。在此之前,1993年至1996年期间,Gruber女士担任Lannet Data Communications Ltd.的控制人,该公司随后被Lucent Technologies Inc.收购。Gruber女士担任TAT科技 Ltd.的外部董事,该公司是一家在纳斯达克和TASE上市的上市公司,自2013年11月起担任Tufin Software Technologies Ltd.的外部董事,该公司是一家自2019年4月起在纽约证券交易所上市的上市公司,并担任Cognyte Ltd.的独立董事,该公司是一家在纳斯达克上市的上市公司。Gruber女士是一名注册会计师,拥有以色列会计和经济学学士学位。


Dafna Gruber has broad experience, serving as chief financial officer and a senior executive management member in leading hi-tech companies traded on both Nasdaq and TASE. From February 2019 until February 2021 Ms. Gruber served as chief financial officer of Aqua security Ltd., a private company. From September 2017 until February 2019 Ms. Gruber served as the chief financial officer of Landa Corporation Ltd., and then as financial advisor to Landa group. From 2015 until 2017 Ms. Gruber served as the chief financial officer of Clal Industries Ltd., a private company. From 2007 until 2015 Ms. Gruber served as the chief financial officer of Nice Systems Ltd., a public company traded on Nasdaq and TASE. As a member of the senior management team, Ms. Gruber was a senior member of the strategy and M&A forum of the company. During her employment with Nice, Ms. Gruber was responsible, inter alia, for finance, operation, MIS and IT, legal and investor relations. From 1996 until 2007 Ms. Gruber was part of Alvarion Ltd., a public company traded on Nasdaq and TASE, mostly as chief financial officer. Prior to that, from 1993 to 1996 Ms. Gruber was a controller at Lannet Data Communications Ltd., subsequently acquired by Lucent Technologies Inc. Ms. Gruber serves as an external director at TAT Technologies Ltd., a public company traded on Nasdaq and TASE, since November 2013 as an external director at Tufin software technologies Ltd., a public company traded on NYSE since April 2019 and as an independent director at Cognyte Ltd, a public company traded on Nasdaq. Ms. Gruber is a certified public accountant and holds a Bachelor's degree in Accounting and Economics from Tel Aviv University, Israel.
Dafna Gruber拥有丰富的经验,曾在在纳斯达克和塔斯社交易的领先高科技公司担任首席财务官和高级执行管理层成员。从2019年2月到2021年2月,Gruber女士担任私营公司Aqua Security Ltd.的首席财务官。从2017年9月至2019年2月,Gruber女士担任Landa Corporation Ltd.的首席财务官,随后担任Landa Group的财务顾问。从2015年到2017年,Gruber女士担任私营公司Clal Industries Ltd.的首席财务官。从2007年到2015年,Gruber女士担任Nice Systems Ltd.的首席财务官,该公司是一家在纳斯达克和TASE上市的上市公司。作为高级管理团队的一员,格鲁伯女士曾是该公司战略与并购论坛的高级成员。在Nice工作期间,Gruber女士除其他外负责财务、运营、MIS和IT、法律和投资者关系。从1996年到2007年,Gruber女士隶属于Alvarion Ltd公司,该公司是一家在纳斯达克和TASE上市的上市公司,主要担任首席财务官。在此之前,1993年至1996年期间,Gruber女士担任Lannet Data Communications Ltd.的控制人,该公司随后被Lucent Technologies Inc.收购。Gruber女士担任TAT科技 Ltd.的外部董事,该公司是一家在纳斯达克和TASE上市的上市公司,自2013年11月起担任Tufin Software Technologies Ltd.的外部董事,该公司是一家自2019年4月起在纽约证券交易所上市的上市公司,并担任Cognyte Ltd.的独立董事,该公司是一家在纳斯达克上市的上市公司。Gruber女士是一名注册会计师,拥有以色列会计和经济学学士学位。
Dafna Gruber has broad experience, serving as chief financial officer and a senior executive management member in leading hi-tech companies traded on both Nasdaq and TASE. From February 2019 until February 2021 Ms. Gruber served as chief financial officer of Aqua security Ltd., a private company. From September 2017 until February 2019 Ms. Gruber served as the chief financial officer of Landa Corporation Ltd., and then as financial advisor to Landa group. From 2015 until 2017 Ms. Gruber served as the chief financial officer of Clal Industries Ltd., a private company. From 2007 until 2015 Ms. Gruber served as the chief financial officer of Nice Systems Ltd., a public company traded on Nasdaq and TASE. As a member of the senior management team, Ms. Gruber was a senior member of the strategy and M&A forum of the company. During her employment with Nice, Ms. Gruber was responsible, inter alia, for finance, operation, MIS and IT, legal and investor relations. From 1996 until 2007 Ms. Gruber was part of Alvarion Ltd., a public company traded on Nasdaq and TASE, mostly as chief financial officer. Prior to that, from 1993 to 1996 Ms. Gruber was a controller at Lannet Data Communications Ltd., subsequently acquired by Lucent Technologies Inc. Ms. Gruber serves as an external director at TAT Technologies Ltd., a public company traded on Nasdaq and TASE, since November 2013 as an external director at Tufin software technologies Ltd., a public company traded on NYSE since April 2019 and as an independent director at Cognyte Ltd, a public company traded on Nasdaq. Ms. Gruber is a certified public accountant and holds a Bachelor's degree in Accounting and Economics from Tel Aviv University, Israel.
Yoav Doppelt

自2006年12月以来Yoav Doppelt担任Yoav Doppelt的董事。Doppelt先生曾担任XY投资公司(XT Investments Ltd)的首席执行官自它成立于2007年,并担任它的全资子公司XI1992技术投资公司(XT Hi-Tech Investments -1992 Ltd)的首席执行官。目前担任多家公司的董事会成员及主席,包括 Enzymotec Ltd., Israel Corporation Ltd., TowerJazz Ltd., MGVS Ltd., Yozma III Management和Investments Ltd., RayV Inc.及Angioslide Ltd.。他拥有以色列海法泰克尼康-以色列理工学院(Technion - Israel Institute of Technology)经济学和管理学士学位 以及以色列海法大学(Haifa University)的MBA学位。


Yoav Doppelt serves as the Chief Executive Officer of Israel Corp. Previoly Mr. Doppelt served as the Chief Executive Officer of Kenon Holdings Ltd., a global company (NYSE: KEN), and Executive Chairman of IC Por Ltd., a por generation company, from March 2014 to September 2017. Prior thereto, Mr. Doppelt was the founder and Chief Executive Officer of the Ofer Group's private equity fund where he was involved in numero investments in the private equity and technology sectors. Mr. Doppelt has served as the Chief Executive Officer of XT Investments (formerly known as XT Capital and Ofer Hi Tech) since 2001. Mr. Doppelt has actively led several public offerings of equity and debt offerings in the and Europe, and he has extensive operational and global biness experience with growth companies. Mr. Doppelt also serves as a director of AKVA Group ASA and previoly served as Chairman of OPC Energy Ltd. (TASE: OPC), and as a director of Zim Integrated Shipping Services Ltd. and of Melisron Ltd. Mr. Doppelt holds a B.Sc. degree in Economics and Management from the Technion – Israel Institute of Technology, and an MBA degree from Haifa University.
自2006年12月以来Yoav Doppelt担任Yoav Doppelt的董事。Doppelt先生曾担任XY投资公司(XT Investments Ltd)的首席执行官自它成立于2007年,并担任它的全资子公司XI1992技术投资公司(XT Hi-Tech Investments -1992 Ltd)的首席执行官。目前担任多家公司的董事会成员及主席,包括 Enzymotec Ltd., Israel Corporation Ltd., TowerJazz Ltd., MGVS Ltd., Yozma III Management和Investments Ltd., RayV Inc.及Angioslide Ltd.。他拥有以色列海法泰克尼康-以色列理工学院(Technion - Israel Institute of Technology)经济学和管理学士学位 以及以色列海法大学(Haifa University)的MBA学位。
Yoav Doppelt serves as the Chief Executive Officer of Israel Corp. Previoly Mr. Doppelt served as the Chief Executive Officer of Kenon Holdings Ltd., a global company (NYSE: KEN), and Executive Chairman of IC Por Ltd., a por generation company, from March 2014 to September 2017. Prior thereto, Mr. Doppelt was the founder and Chief Executive Officer of the Ofer Group's private equity fund where he was involved in numero investments in the private equity and technology sectors. Mr. Doppelt has served as the Chief Executive Officer of XT Investments (formerly known as XT Capital and Ofer Hi Tech) since 2001. Mr. Doppelt has actively led several public offerings of equity and debt offerings in the and Europe, and he has extensive operational and global biness experience with growth companies. Mr. Doppelt also serves as a director of AKVA Group ASA and previoly served as Chairman of OPC Energy Ltd. (TASE: OPC), and as a director of Zim Integrated Shipping Services Ltd. and of Melisron Ltd. Mr. Doppelt holds a B.Sc. degree in Economics and Management from the Technion – Israel Institute of Technology, and an MBA degree from Haifa University.
Michal Silverberg

Michal Silverberg,于2013年9月担任Enzymotec公司董事。自2007年,她就职于总部设在丹麦的跨国医疗保健公司Novo Nordisk Inc.公司,该公司股票在哥本哈根和纽约证券交易所(Copenhagen and New York Stock Exchanges)上市。自2010年起她担任生物药剂学新产品商业化及商业开发的资深总监。加入Novo Nordisk公司之前,她在生物技术公司投资部门多个职位工作,并担任以色列科技培养中心(Israel Technological Incubators)首席科学家。她在以色列海法大学(Haifa University, Israel)获得经济学和工商管理学士,并在以色列特拉维斯大学(Tel Aviv University, Israel)获得MBA,在纽约市哥伦比亚大学(Columbia University, New York)获得生物技术专业硕士学位。


Michal Silverberg has been a member of our board of directors since October 2017. Ms. Silverberg current serves as a Managing Director at the Novartis Venture Fund, where she has been employed since October 2017. Prior to joining Novartis Venture Fund, she was a Senior Partner at Takeda Ventures from September 2014 through September 2017 and, before that, worked at Novo Nordisk from March 2007 through April 2013 in roles of increasing responsibility including as Senior Director Business Development and New Product Commercialization, serving as a member of the BioPharm leadership team. Since 1998 Ms. Silverberg has held positions in various sectors of the life science industry including in the Office of the Chief Scientist of Israel The Incubator program, venture capital (Ofer Brothers Hi Tech) and global pharmaceutical and biotech companies, including various positions at Multi Gene Vascular Systems Ltd., an Israeli biotech company and at OSI Pharmaceuticals in a business development role. Ms. Silverberg served as a member of the board of directors of publicly traded company Enzymotec Ltd. from its initial public offering in September 2013 until the company was acquired in October 2017. Ms. Silverberg holds a B.A. in economics and business management from Haifa University, an M.B.A from Tel-Aviv University in Israel and an M.A. in biotechnology from Columbia University. Ms. Silverberg resigned from our board of directors effective June 18 2020. Ms. Silverberg’s resignation was not due to any disagreement with the Company or any matters relating to our operations, policies or practices.
Michal Silverberg,于2013年9月担任Enzymotec公司董事。自2007年,她就职于总部设在丹麦的跨国医疗保健公司Novo Nordisk Inc.公司,该公司股票在哥本哈根和纽约证券交易所(Copenhagen and New York Stock Exchanges)上市。自2010年起她担任生物药剂学新产品商业化及商业开发的资深总监。加入Novo Nordisk公司之前,她在生物技术公司投资部门多个职位工作,并担任以色列科技培养中心(Israel Technological Incubators)首席科学家。她在以色列海法大学(Haifa University, Israel)获得经济学和工商管理学士,并在以色列特拉维斯大学(Tel Aviv University, Israel)获得MBA,在纽约市哥伦比亚大学(Columbia University, New York)获得生物技术专业硕士学位。
Michal Silverberg has been a member of our board of directors since October 2017. Ms. Silverberg current serves as a Managing Director at the Novartis Venture Fund, where she has been employed since October 2017. Prior to joining Novartis Venture Fund, she was a Senior Partner at Takeda Ventures from September 2014 through September 2017 and, before that, worked at Novo Nordisk from March 2007 through April 2013 in roles of increasing responsibility including as Senior Director Business Development and New Product Commercialization, serving as a member of the BioPharm leadership team. Since 1998 Ms. Silverberg has held positions in various sectors of the life science industry including in the Office of the Chief Scientist of Israel The Incubator program, venture capital (Ofer Brothers Hi Tech) and global pharmaceutical and biotech companies, including various positions at Multi Gene Vascular Systems Ltd., an Israeli biotech company and at OSI Pharmaceuticals in a business development role. Ms. Silverberg served as a member of the board of directors of publicly traded company Enzymotec Ltd. from its initial public offering in September 2013 until the company was acquired in October 2017. Ms. Silverberg holds a B.A. in economics and business management from Haifa University, an M.B.A from Tel-Aviv University in Israel and an M.A. in biotechnology from Columbia University. Ms. Silverberg resigned from our board of directors effective June 18 2020. Ms. Silverberg’s resignation was not due to any disagreement with the Company or any matters relating to our operations, policies or practices.

高管简历

中英对照 |  中文 |  英文
Amir Meshulam

Amir Meshulam自2018年8月起担任全球内部审计师。Meshulam先生是以色列的注册会计师,拥有管理学院的法学学士学位,并且是Israel Bar成员。Meshulam先生是公司员工,向董事会执行主席报告。


Amir Meshulam has served as Global Internal Auditor since Augt 2018. Mr. Meshulam is a certified public accountant in Israel, and holds an LLB degree from the College of Management and is a member of the Israel Bar. Mr. Meshulam is a Company employee, and reports to the Executive Chairman of the Board of Directors.
Amir Meshulam自2018年8月起担任全球内部审计师。Meshulam先生是以色列的注册会计师,拥有管理学院的法学学士学位,并且是Israel Bar成员。Meshulam先生是公司员工,向董事会执行主席报告。
Amir Meshulam has served as Global Internal Auditor since Augt 2018. Mr. Meshulam is a certified public accountant in Israel, and holds an LLB degree from the College of Management and is a member of the Israel Bar. Mr. Meshulam is a Company employee, and reports to the Executive Chairman of the Board of Directors.
Anantha N. Desikan

AnanthaN.Desikan于2018年11月被任命为ICL的首席创新技术官,并于2019年11月1日晋升为执行副总裁。Desikan博士于2007年加入ICL,在此之前曾担任高级商业和技术管理职务,包括ICL Industrial Products’;阻燃剂业务高级副总裁2014-2018ICL-IP America总裁(2013-2015)和全球磷研发副总裁(2007-2013)。在2007年加入ICL之前,Desikan博士在Supresta和Akzo Nobel担任技术管理职位。Desikan先生拥有纽约波茨坦克拉克森大学(Clarkson University,Potsdam)的化学工程博士学位和硕士学位,以及印度马德拉斯大学(Madras University)Coimbatore理工学院的化学工程学士学位。


Anantha N. Desikan was appointed Chief Innovation & Technology Officer of ICL in November 2018 and was promoted to EVP in November 2019. Dr. Desikan joined ICL in 2007 and has served in senior commercial and technology management roles including Senior Vice President of ICL Indtrial Products' Flame Retardants biness (2014 2018), President, ICL IP America (2013 2015) and VP Global Phosphoro R&D (2007 2013). Prior to joining ICL in 2007, Dr. Desikan held technology management roles at Supresta and Akzo Nobel. Mr. Desikan holds a Ph.D and M.S degree in Chemical Engineering from Clarkson University, Potsdam, New York, and a B.S. degree in Chemical Engineering from Coimbatore Institute of Technology, Madras University, India.
AnanthaN.Desikan于2018年11月被任命为ICL的首席创新技术官,并于2019年11月1日晋升为执行副总裁。Desikan博士于2007年加入ICL,在此之前曾担任高级商业和技术管理职务,包括ICL Industrial Products’;阻燃剂业务高级副总裁2014-2018ICL-IP America总裁(2013-2015)和全球磷研发副总裁(2007-2013)。在2007年加入ICL之前,Desikan博士在Supresta和Akzo Nobel担任技术管理职位。Desikan先生拥有纽约波茨坦克拉克森大学(Clarkson University,Potsdam)的化学工程博士学位和硕士学位,以及印度马德拉斯大学(Madras University)Coimbatore理工学院的化学工程学士学位。
Anantha N. Desikan was appointed Chief Innovation & Technology Officer of ICL in November 2018 and was promoted to EVP in November 2019. Dr. Desikan joined ICL in 2007 and has served in senior commercial and technology management roles including Senior Vice President of ICL Indtrial Products' Flame Retardants biness (2014 2018), President, ICL IP America (2013 2015) and VP Global Phosphoro R&D (2007 2013). Prior to joining ICL in 2007, Dr. Desikan held technology management roles at Supresta and Akzo Nobel. Mr. Desikan holds a Ph.D and M.S degree in Chemical Engineering from Clarkson University, Potsdam, New York, and a B.S. degree in Chemical Engineering from Coimbatore Institute of Technology, Madras University, India.
Ilana Fahima

Ilana Fahima于2018年11月被任命为全球人力资源执行Vice President。在加入ICL之前,Fahima女士曾担任Teva Pharmaceutical Industries Ltd.全球质量Vice President人力资源和以色列人力资源主管。加入Teva公司之前,她曾担任MacCabi Health Services公司的多种职务,其中包括区域人力资源董事、区域服务经理。Fahima女士拥有Ben Gurion University的社会工作学士学位和医疗保健管理工商管理硕士学位。


Ilana Fahima has served as EVP, Chief People Officer, since November 2018. Prior to joining ICL, Ms. Fahima served as Vice President HR for Global Quality and Head of Israel HR at Teva Pharmaceutical Indtries Ltd. Before joining Teva, Ms. Fahima held several positions at Maccabi Health Services, among them Regional HR Director and Regional Service Manager. Ms. Fahima holds a BA degree in Social Work and an MBA degree in Health Care Management, both from Ben Gurion University.
Ilana Fahima于2018年11月被任命为全球人力资源执行Vice President。在加入ICL之前,Fahima女士曾担任Teva Pharmaceutical Industries Ltd.全球质量Vice President人力资源和以色列人力资源主管。加入Teva公司之前,她曾担任MacCabi Health Services公司的多种职务,其中包括区域人力资源董事、区域服务经理。Fahima女士拥有Ben Gurion University的社会工作学士学位和医疗保健管理工商管理硕士学位。
Ilana Fahima has served as EVP, Chief People Officer, since November 2018. Prior to joining ICL, Ms. Fahima served as Vice President HR for Global Quality and Head of Israel HR at Teva Pharmaceutical Indtries Ltd. Before joining Teva, Ms. Fahima held several positions at Maccabi Health Services, among them Regional HR Director and Regional Service Manager. Ms. Fahima holds a BA degree in Social Work and an MBA degree in Health Care Management, both from Ben Gurion University.
Lilach Geva Harel

Lilach Geva Harel于2018年12月27日被董事会任命为ICL全球总法律顾问高级副总裁,于2019年2月1日上任。在加入ICL之前,从2009年起,Geva-Harel女士担任Psagot Investment House Ltd.首席执行官的高级副总裁兼Investments House总部的负责人,以及总法律顾问。她此前曾担任Gross,Kleinhendler,Hodak,Halevy,Greenberg&Co律师事务所的并购部门的合伙人。Geva-Harel女士拥有巴伊兰大学(Bar Ilan University)的法学学士学位和法学硕士学位,并且是以色列律师协会(Israel Bar)的成员。


Lilach Geva Harel has served as ICL's Deputy CEO since January 2026. Prior to this role, Mrs. Geva Harel served as ICL's EVP, Chief Legal and Stainability Officer from February 1, 2019. Before joining ICL, from 2009 Mrs. Geva Harel served as Senior Deputy to the Chief Executive Officer and Head of Investments Hoe's Headquarters of Psagot Investment Hoe Ltd., as ll as its General Legal Counsel. Mrs. Geva Harel was previoly a Partner in the Merger & Acquisitions Department at Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co. Law Offices. Mrs. Geva Harel served as a director at REE Automotive Ltd. (NYSE: REE), a global company. Mrs. Geva Harel holds an LLB degree and an LLM degree, both from Bar Ilan University and is a member of the Israel Bar.
Lilach Geva Harel于2018年12月27日被董事会任命为ICL全球总法律顾问高级副总裁,于2019年2月1日上任。在加入ICL之前,从2009年起,Geva-Harel女士担任Psagot Investment House Ltd.首席执行官的高级副总裁兼Investments House总部的负责人,以及总法律顾问。她此前曾担任Gross,Kleinhendler,Hodak,Halevy,Greenberg&Co律师事务所的并购部门的合伙人。Geva-Harel女士拥有巴伊兰大学(Bar Ilan University)的法学学士学位和法学硕士学位,并且是以色列律师协会(Israel Bar)的成员。
Lilach Geva Harel has served as ICL's Deputy CEO since January 2026. Prior to this role, Mrs. Geva Harel served as ICL's EVP, Chief Legal and Stainability Officer from February 1, 2019. Before joining ICL, from 2009 Mrs. Geva Harel served as Senior Deputy to the Chief Executive Officer and Head of Investments Hoe's Headquarters of Psagot Investment Hoe Ltd., as ll as its General Legal Counsel. Mrs. Geva Harel was previoly a Partner in the Merger & Acquisitions Department at Gross, Kleinhendler, Hodak, Halevy, Greenberg & Co. Law Offices. Mrs. Geva Harel served as a director at REE Automotive Ltd. (NYSE: REE), a global company. Mrs. Geva Harel holds an LLB degree and an LLM degree, both from Bar Ilan University and is a member of the Israel Bar.
Miri Mishor

Miri Mishor自2014年以来一直担任ICL信息技术高级副总裁,。Mishor女士于1986年加入ICL并担任多个职位,包括ICL工业产品的首席信息官和ICL化肥的Vice President信息系统。Mishor女士拥有工商管理学士学位。数学和计算机科学学位以及理学硕士学位。Ben Gurion University工业管理学位。


Miri Mishor has served as EVP, Global Information Technology since 2022. Mrs. Mishor joined ICL in 1986 and served in vario positions, including CIO of ICL Indtrial Products, VP Information Systems of ICL Fertilizers and SVP, ICL Information Technology. Mrs. Mishor holds a B.Sc. degree in Mathematics and Computer Science and a M.Sc. degree in Indtrial Management from Ben Gurion University.
Miri Mishor自2014年以来一直担任ICL信息技术高级副总裁,。Mishor女士于1986年加入ICL并担任多个职位,包括ICL工业产品的首席信息官和ICL化肥的Vice President信息系统。Mishor女士拥有工商管理学士学位。数学和计算机科学学位以及理学硕士学位。Ben Gurion University工业管理学位。
Miri Mishor has served as EVP, Global Information Technology since 2022. Mrs. Mishor joined ICL in 1986 and served in vario positions, including CIO of ICL Indtrial Products, VP Information Systems of ICL Fertilizers and SVP, ICL Information Technology. Mrs. Mishor holds a B.Sc. degree in Mathematics and Computer Science and a M.Sc. degree in Indtrial Management from Ben Gurion University.
Ilan Barkai

Ilan Barkai自2025年5月起担任ICL钾肥部门总裁兼以色列磷酸盐业务负责人。Barkai先生还负责监督Rotem网站并担任ICL的全球EHS负责人。Barkai先生于2021年加入ICL,担任磷酸盐以色列运营和EHS高级副总裁。在加入ICL之前,Barkai先生曾在梯瓦制药担任两个高级领导职务,分别是Site总经理和高级总监、干式生产和运营生态经理(2014 – 2021),在此期间,他负责监督复杂的制造工艺和大规模团队。在其职业生涯的早期,Barkai先生曾在美光科技担任制造经理(2007 – 2014),在英特尔公司担任制造集团负责人(2003 – 2007)。Ilan拥有Negev的Ben Gurion大学Biness Administration学士学位。


Ilan Barkai has served as President of ICL's Potash Division and Head of Israel Phosphate Operations since May 2025. Mr. Barkai also oversees the Rotem site and acts as ICL's Global EHS leader. Mr. Barkai joined ICL in 2021 as Senior Vice President of Phosphate Israel Operations & EHS. Before joining ICL, Mr. Barkai held two senior leadership roles at Teva Pharmaceuticals, as Site General Manager and as Senior Director, Dry Production & Operational Ecology Manager (2014–2021), during which he oversaw complex manufacturing processes and large scale teams. Earlier in his career, Mr. Barkai worked as Manufacturing Manager at Micron Technology (2007–2014) and as a Manufacturing Group Leader at Intel Corporation (2003–2007). Ilan has a BA degree in Biness Administration from Ben Gurion University of the Negev.
Ilan Barkai自2025年5月起担任ICL钾肥部门总裁兼以色列磷酸盐业务负责人。Barkai先生还负责监督Rotem网站并担任ICL的全球EHS负责人。Barkai先生于2021年加入ICL,担任磷酸盐以色列运营和EHS高级副总裁。在加入ICL之前,Barkai先生曾在梯瓦制药担任两个高级领导职务,分别是Site总经理和高级总监、干式生产和运营生态经理(2014 – 2021),在此期间,他负责监督复杂的制造工艺和大规模团队。在其职业生涯的早期,Barkai先生曾在美光科技担任制造经理(2007 – 2014),在英特尔公司担任制造集团负责人(2003 – 2007)。Ilan拥有Negev的Ben Gurion大学Biness Administration学士学位。
Ilan Barkai has served as President of ICL's Potash Division and Head of Israel Phosphate Operations since May 2025. Mr. Barkai also oversees the Rotem site and acts as ICL's Global EHS leader. Mr. Barkai joined ICL in 2021 as Senior Vice President of Phosphate Israel Operations & EHS. Before joining ICL, Mr. Barkai held two senior leadership roles at Teva Pharmaceuticals, as Site General Manager and as Senior Director, Dry Production & Operational Ecology Manager (2014–2021), during which he oversaw complex manufacturing processes and large scale teams. Earlier in his career, Mr. Barkai worked as Manufacturing Manager at Micron Technology (2007–2014) and as a Manufacturing Group Leader at Intel Corporation (2003–2007). Ilan has a BA degree in Biness Administration from Ben Gurion University of the Negev.
Maya Grinfeld

Maya Grinfeld自2019年9月起担任ICL全球营销与传播高级副总裁,自2024年5月起被视为公司的公职人员。此前担任的职务包括2017年至2019年担任领先家居设计集团公司Negev Group的营销副总裁,以及2006年至2017年担任Caesarstone Ltd.(NASDAQ:CSTE)的国际营销主管。此外,Grinfeld女士从2000年至2005年担任Inclarity的营销经理,从1997年至2000年担任以色列航空公司(OTC:ELAL/TA:ELAL)的运营主管。Grinfeld女士拥有海法大学MBA学位和伦敦城市大学法学学士学位。


Maya Grinfeld has served as SVP, ICL Global Marketing & Communications, since September 2019 and is considered an office holder of the Company since May 2024. Prior roles include VP of Marketing of a leading home design group company Negev Group from 2017 2019, and Head of International Marketing at Caesarstone Ltd. (NASDAQ: CSTE) from 2006 2017. In addition, Ms. Grinfeld served as Marketing Manager at Inclarity from 2000 2005 and as Head of Operations in El Al Israel Airlines (OTC: ELAL/TA: ELAL) from 1997 2000. Ms. Grinfeld holds an MBA degree from University of Haifa and an LLB degree from London Metropolitan University.
Maya Grinfeld自2019年9月起担任ICL全球营销与传播高级副总裁,自2024年5月起被视为公司的公职人员。此前担任的职务包括2017年至2019年担任领先家居设计集团公司Negev Group的营销副总裁,以及2006年至2017年担任Caesarstone Ltd.(NASDAQ:CSTE)的国际营销主管。此外,Grinfeld女士从2000年至2005年担任Inclarity的营销经理,从1997年至2000年担任以色列航空公司(OTC:ELAL/TA:ELAL)的运营主管。Grinfeld女士拥有海法大学MBA学位和伦敦城市大学法学学士学位。
Maya Grinfeld has served as SVP, ICL Global Marketing & Communications, since September 2019 and is considered an office holder of the Company since May 2024. Prior roles include VP of Marketing of a leading home design group company Negev Group from 2017 2019, and Head of International Marketing at Caesarstone Ltd. (NASDAQ: CSTE) from 2006 2017. In addition, Ms. Grinfeld served as Marketing Manager at Inclarity from 2000 2005 and as Head of Operations in El Al Israel Airlines (OTC: ELAL/TA: ELAL) from 1997 2000. Ms. Grinfeld holds an MBA degree from University of Haifa and an LLB degree from London Metropolitan University.
Nir Ilani

Nir Ilani自2025年5月起担任ICL不断增长的解决方案BINCE总裁。在加入ICL之前,Ilani先生曾担任Klil Indtries Ltd.的首席执行官(2024 – 2025)、Prodalim Group总裁(2021 – 2023),以及IFF全球美味和冰淇淋解决方案部门总裁(2016 – 2021),负责监督多项并购计划并管理多元化的多元文化团队。在其职业生涯的早期,Ilani先生曾在以色列的联合利华 Food Solutions和Rsia担任高级领导职务(2010 – 2016),曾在Kafrit Group担任国际销售和营销副总裁(2007 – 2009),并在雀巢以色列公司领导商业运营(2002 – 2007)。Nir拥有内盖夫本古里安大学经济学和BINES管理学士学位。


Nir Ilani has served as President of ICL's Growing Solutions biness since May 2025. Prior to joining ICL, Mr. Ilani served as CEO of Klil Indtries Ltd. (2024–2025), President of Prodalim Group (2021–2023), and President of the Global Savory & Ice Cream Solutions Division at IFF (2016–2021), where he oversaw multiple M&A initiatives and managed diverse multicultural teams. Earlier in his career, Mr. Ilani held senior leadership roles at Unilever Food Solutions in Israel and Rsia (2010–2016), served as VP of International Sales and Marketing at Kafrit Group (2007–2009), and led commercial operations at Nestlé Israel (2002–2007). Nir holds a BA degree in Economics and Biness Management from Ben Gurion University of the Negev.
Nir Ilani自2025年5月起担任ICL不断增长的解决方案BINCE总裁。在加入ICL之前,Ilani先生曾担任Klil Indtries Ltd.的首席执行官(2024 – 2025)、Prodalim Group总裁(2021 – 2023),以及IFF全球美味和冰淇淋解决方案部门总裁(2016 – 2021),负责监督多项并购计划并管理多元化的多元文化团队。在其职业生涯的早期,Ilani先生曾在以色列的联合利华 Food Solutions和Rsia担任高级领导职务(2010 – 2016),曾在Kafrit Group担任国际销售和营销副总裁(2007 – 2009),并在雀巢以色列公司领导商业运营(2002 – 2007)。Nir拥有内盖夫本古里安大学经济学和BINES管理学士学位。
Nir Ilani has served as President of ICL's Growing Solutions biness since May 2025. Prior to joining ICL, Mr. Ilani served as CEO of Klil Indtries Ltd. (2024–2025), President of Prodalim Group (2021–2023), and President of the Global Savory & Ice Cream Solutions Division at IFF (2016–2021), where he oversaw multiple M&A initiatives and managed diverse multicultural teams. Earlier in his career, Mr. Ilani held senior leadership roles at Unilever Food Solutions in Israel and Rsia (2010–2016), served as VP of International Sales and Marketing at Kafrit Group (2007–2009), and led commercial operations at Nestlé Israel (2002–2007). Nir holds a BA degree in Economics and Biness Management from Ben Gurion University of the Negev.
Nadav Turner

Nadav Turner自2025年5月起担任ICL磷酸盐解决方案部门总裁。在担任此职务之前,Turner先生于2019年5月至2025年4月期间担任ICL在中国的合资企业YPH的首席执行官。Nadav于2010年加入ICL,曾在ICL Rotem Amfert担任多个高级运营领导职务,在推动生产效率和运营转型方面发挥了关键作用。在他职业生涯的早期,他曾担任Vishay的DBR以色列工厂的运营总监(2006年至2009年)。Nadav拥有内盖夫本古里安大学信息系统工程理学学士学位。


Nadav Turner has served as President of ICL's Phosphate Solutions Division since May 2025. Prior to this role, Mr. Turner served as CEO of YPH, ICL's joint venture in China, from May 2019 to April 2025. Nadav joined ICL in 2010 and has held several senior operational leadership positions at ICL Rotem Amfert, where he played a key role in driving production efficiency and operational transformation. Earlier in his career, he served as Director of Operations at Vishay's DBR Israel facility (2006 to 2009). Nadav holds a B.Sc. degree in Information Systems Engineering from Ben Gurion University of the Negev.
Nadav Turner自2025年5月起担任ICL磷酸盐解决方案部门总裁。在担任此职务之前,Turner先生于2019年5月至2025年4月期间担任ICL在中国的合资企业YPH的首席执行官。Nadav于2010年加入ICL,曾在ICL Rotem Amfert担任多个高级运营领导职务,在推动生产效率和运营转型方面发挥了关键作用。在他职业生涯的早期,他曾担任Vishay的DBR以色列工厂的运营总监(2006年至2009年)。Nadav拥有内盖夫本古里安大学信息系统工程理学学士学位。
Nadav Turner has served as President of ICL's Phosphate Solutions Division since May 2025. Prior to this role, Mr. Turner served as CEO of YPH, ICL's joint venture in China, from May 2019 to April 2025. Nadav joined ICL in 2010 and has held several senior operational leadership positions at ICL Rotem Amfert, where he played a key role in driving production efficiency and operational transformation. Earlier in his career, he served as Director of Operations at Vishay's DBR Israel facility (2006 to 2009). Nadav holds a B.Sc. degree in Information Systems Engineering from Ben Gurion University of the Negev.
Uri Perelman

Uri Perelman自2023年12月起担任执行副总裁、ICL首席企业BINCE开发官。在加入ICL之前,Perelman先生曾在Similarb Ltd.(NYSE:SMWB)担任企业发展领导职务,并在NICE Ltd.(NASDAQ:NICE)担任首席企业发展官,担任并购、合作伙伴和企业发展主管。在加入NICE之前,Perelman先生是Orange SA(NYSE:ORAN)企业发展团队的一员,在那里他领导着全球商业部门和全球合作伙伴关系,在此之前,他任职于Everest Funds,这是一家专门从事激进投资和特殊情况的全球对冲基金。Perelman先生拥有特拉维夫大学MBA学位和学士学位,毕业于伯克利哈斯行政管理课程。


Uri Perelman has served as EVP, ICL Chief Corporate Biness Development Officer since December 2023. Prior to joining ICL, Mr. Perelman held corporate development leadership roles at Similarb Ltd. (NYSE: SMWB), where he served as Chief Corporate Development Officer, and at NICE Ltd. (NASDAQ:NICE), where he was the Head of M&A, Partners, and Corporate Development. Prior to NICE, Mr. Perelman was part of the corporate development team at Orange SA (NYSE: ORAN), where he led the global commercial department and partnerships worldwide and before that at Everest Funds, a global hedge fund specializing in activist investing and special situations. Mr. Perelman holds an MBA degree and a BA degree from Tel Aviv University and is a graduate of Berkeley Haas Executive Management program.
Uri Perelman自2023年12月起担任执行副总裁、ICL首席企业BINCE开发官。在加入ICL之前,Perelman先生曾在Similarb Ltd.(NYSE:SMWB)担任企业发展领导职务,并在NICE Ltd.(NASDAQ:NICE)担任首席企业发展官,担任并购、合作伙伴和企业发展主管。在加入NICE之前,Perelman先生是Orange SA(NYSE:ORAN)企业发展团队的一员,在那里他领导着全球商业部门和全球合作伙伴关系,在此之前,他任职于Everest Funds,这是一家专门从事激进投资和特殊情况的全球对冲基金。Perelman先生拥有特拉维夫大学MBA学位和学士学位,毕业于伯克利哈斯行政管理课程。
Uri Perelman has served as EVP, ICL Chief Corporate Biness Development Officer since December 2023. Prior to joining ICL, Mr. Perelman held corporate development leadership roles at Similarb Ltd. (NYSE: SMWB), where he served as Chief Corporate Development Officer, and at NICE Ltd. (NASDAQ:NICE), where he was the Head of M&A, Partners, and Corporate Development. Prior to NICE, Mr. Perelman was part of the corporate development team at Orange SA (NYSE: ORAN), where he led the global commercial department and partnerships worldwide and before that at Everest Funds, a global hedge fund specializing in activist investing and special situations. Mr. Perelman holds an MBA degree and a BA degree from Tel Aviv University and is a graduate of Berkeley Haas Executive Management program.
Yaniv Kabalek

Yaniv Kabalek自2022年9月起担任Indtrial产品部门总裁。自2001年以来,Kabalek先生曾在ICL担任过多个领导职务:担任高级副总裁,阻燃剂,必能发展。& Advocacy自2019年起至2022年;自2017年起至2019年担任高级副总裁,负责ICL IP区域销售中国/亚洲& ICL亚洲总部(位于中国);自2014年至2017年担任副总裁,负责ICL IP区域销售中国/亚洲(位于香港);自2012年至2014年担任全球营销Bromine & Isotank主管,自2007年至2012年担任ICLTERM3 IP全球财务经理;自2001年至2006年担任财务分析师。Kabalek先生拥有本古里安大学的经济学学士学位和BINCE Administration硕士学位。


Yaniv Kabalek has served as President of Indtrial Products Division since September 2022. Since 2001, Mr. Kabalek has served in several leadership positions at ICL: as Senior VP, Flame Retardants, Biness Develop. & Advocacy from 2019 2022; as Senior Vice President, ICL IP Regional Sales China/Asia & ICL Asia HQ (located in China) from 2017 2019; as Vice President, ICL IP Regional Sales China/Asia (located in HK) from 2014 2017; as Head of Global Marketing Bromine & Isotanks from 2012 2014, as ICL IP Global Treasury Manager from 2007 2012; and as a financial analyst from 2001 2006. Mr. Kabalek holds a BA degree in Economics and an MA degree in Biness Administration, both from Ben Gurion University.
Yaniv Kabalek自2022年9月起担任Indtrial产品部门总裁。自2001年以来,Kabalek先生曾在ICL担任过多个领导职务:担任高级副总裁,阻燃剂,必能发展。& Advocacy自2019年起至2022年;自2017年起至2019年担任高级副总裁,负责ICL IP区域销售中国/亚洲& ICL亚洲总部(位于中国);自2014年至2017年担任副总裁,负责ICL IP区域销售中国/亚洲(位于香港);自2012年至2014年担任全球营销Bromine & Isotank主管,自2007年至2012年担任ICLTERM3 IP全球财务经理;自2001年至2006年担任财务分析师。Kabalek先生拥有本古里安大学的经济学学士学位和BINCE Administration硕士学位。
Yaniv Kabalek has served as President of Indtrial Products Division since September 2022. Since 2001, Mr. Kabalek has served in several leadership positions at ICL: as Senior VP, Flame Retardants, Biness Develop. & Advocacy from 2019 2022; as Senior Vice President, ICL IP Regional Sales China/Asia & ICL Asia HQ (located in China) from 2017 2019; as Vice President, ICL IP Regional Sales China/Asia (located in HK) from 2014 2017; as Head of Global Marketing Bromine & Isotanks from 2012 2014, as ICL IP Global Treasury Manager from 2007 2012; and as a financial analyst from 2001 2006. Mr. Kabalek holds a BA degree in Economics and an MA degree in Biness Administration, both from Ben Gurion University.
Elad Aharonson

Elad Aharonson, 自2009年以来在无人机系统担任副总裁后,2011年被任命为无人机系统部门的执行副总裁兼总经理。2004年,他加入了埃尔比特系统公司,并担任有关无人机的各种高级项目管理职位。在此之前,他曾担任炮兵科和地面部队无人机单位以色列国防军指挥军官。他拥有希伯来大学法律学法学士学位和工商管理学士学位。


Elad Aharonson has served as Executive Vice President and General Manager - ISTAR Division since 2015. From 2011 until his current appointment, he served as executive vice president and general manager - UAS Division, after serving as vice president - UAV systems since 2009. He joined Elbit Systems in 2004 and held various senior program management positions relating to UAS. Prior to that, Mr. Aharonson served as an officer in the IDF holding command positions in the Artillery Branch and in the Ground Forces’ UAV unit. Mr. Aharonson holds a law degree LL.B. and a bachelor’s degree in business administration from the Hebrew University.
Elad Aharonson, 自2009年以来在无人机系统担任副总裁后,2011年被任命为无人机系统部门的执行副总裁兼总经理。2004年,他加入了埃尔比特系统公司,并担任有关无人机的各种高级项目管理职位。在此之前,他曾担任炮兵科和地面部队无人机单位以色列国防军指挥军官。他拥有希伯来大学法律学法学士学位和工商管理学士学位。
Elad Aharonson has served as Executive Vice President and General Manager - ISTAR Division since 2015. From 2011 until his current appointment, he served as executive vice president and general manager - UAS Division, after serving as vice president - UAV systems since 2009. He joined Elbit Systems in 2004 and held various senior program management positions relating to UAS. Prior to that, Mr. Aharonson served as an officer in the IDF holding command positions in the Artillery Branch and in the Ground Forces’ UAV unit. Mr. Aharonson holds a law degree LL.B. and a bachelor’s degree in business administration from the Hebrew University.
Yoav Doppelt

自2006年12月以来Yoav Doppelt担任Yoav Doppelt的董事。Doppelt先生曾担任XY投资公司(XT Investments Ltd)的首席执行官自它成立于2007年,并担任它的全资子公司XI1992技术投资公司(XT Hi-Tech Investments -1992 Ltd)的首席执行官。目前担任多家公司的董事会成员及主席,包括 Enzymotec Ltd., Israel Corporation Ltd., TowerJazz Ltd., MGVS Ltd., Yozma III Management和Investments Ltd., RayV Inc.及Angioslide Ltd.。他拥有以色列海法泰克尼康-以色列理工学院(Technion - Israel Institute of Technology)经济学和管理学士学位 以及以色列海法大学(Haifa University)的MBA学位。


Yoav Doppelt serves as the Chief Executive Officer of Israel Corp. Previoly Mr. Doppelt served as the Chief Executive Officer of Kenon Holdings Ltd., a global company (NYSE: KEN), and Executive Chairman of IC Por Ltd., a por generation company, from March 2014 to September 2017. Prior thereto, Mr. Doppelt was the founder and Chief Executive Officer of the Ofer Group's private equity fund where he was involved in numero investments in the private equity and technology sectors. Mr. Doppelt has served as the Chief Executive Officer of XT Investments (formerly known as XT Capital and Ofer Hi Tech) since 2001. Mr. Doppelt has actively led several public offerings of equity and debt offerings in the and Europe, and he has extensive operational and global biness experience with growth companies. Mr. Doppelt also serves as a director of AKVA Group ASA and previoly served as Chairman of OPC Energy Ltd. (TASE: OPC), and as a director of Zim Integrated Shipping Services Ltd. and of Melisron Ltd. Mr. Doppelt holds a B.Sc. degree in Economics and Management from the Technion – Israel Institute of Technology, and an MBA degree from Haifa University.
自2006年12月以来Yoav Doppelt担任Yoav Doppelt的董事。Doppelt先生曾担任XY投资公司(XT Investments Ltd)的首席执行官自它成立于2007年,并担任它的全资子公司XI1992技术投资公司(XT Hi-Tech Investments -1992 Ltd)的首席执行官。目前担任多家公司的董事会成员及主席,包括 Enzymotec Ltd., Israel Corporation Ltd., TowerJazz Ltd., MGVS Ltd., Yozma III Management和Investments Ltd., RayV Inc.及Angioslide Ltd.。他拥有以色列海法泰克尼康-以色列理工学院(Technion - Israel Institute of Technology)经济学和管理学士学位 以及以色列海法大学(Haifa University)的MBA学位。
Yoav Doppelt serves as the Chief Executive Officer of Israel Corp. Previoly Mr. Doppelt served as the Chief Executive Officer of Kenon Holdings Ltd., a global company (NYSE: KEN), and Executive Chairman of IC Por Ltd., a por generation company, from March 2014 to September 2017. Prior thereto, Mr. Doppelt was the founder and Chief Executive Officer of the Ofer Group's private equity fund where he was involved in numero investments in the private equity and technology sectors. Mr. Doppelt has served as the Chief Executive Officer of XT Investments (formerly known as XT Capital and Ofer Hi Tech) since 2001. Mr. Doppelt has actively led several public offerings of equity and debt offerings in the and Europe, and he has extensive operational and global biness experience with growth companies. Mr. Doppelt also serves as a director of AKVA Group ASA and previoly served as Chairman of OPC Energy Ltd. (TASE: OPC), and as a director of Zim Integrated Shipping Services Ltd. and of Melisron Ltd. Mr. Doppelt holds a B.Sc. degree in Economics and Management from the Technion – Israel Institute of Technology, and an MBA degree from Haifa University.
Aviram Lahav

Aviram Lahav,男,1959年出生,拥有以色列国籍。他拥有学士学位(经济学和金融学学士学位,以及机械工程学位),并参加了哈佛商学院的高级管理课程(AMP)。Aviram Lahav是一名注册会计师。他曾担任MCA Inc.(菲亚特集团在以色列的授权经销商)的首席财务官,Europcar以色列子公司(一家汽车租赁公司)的首席执行官,Delta Galil Industries Ltd.的集团首席财务官,Delta Galil Industries Ltd.的美国子公司的首席执行官。他还担任Synergy Cables Ltd.(当时在特拉维夫证券交易所上市的一家上市公司)的首席执行官。他目前是ADAMA的执行副总裁兼首席财务官。


Aviram Lahav, male, born in 1959, holds Israeli nationality.He has a bachelor's degree (Bachelor of Economics and Finance, as well as a degree in Mechanical Engineering) and has participated in the Advanced Management Program (AMP) at Harvard Business School.Aviram Lahav is a certified public accountant.He has previously served as the Chief Financial Officer of MCA Inc., an authorized dealer of the Fiat Group in Israel, the Chief Executive Officer of Europcar's Israeli subsidiary (a car rental company),the Group Chief Financial Officer of Delta Galil Industries Ltd., the Chief Executive Officer of Delta Galil Industries Ltd.'s U.S.subsidiary, and the Chief Financial Officer and Chief Operating Officer of Delta Galil Industries Ltd.He also served as the Chief Executive Officer of Synergy Cables Ltd.(which was a publicly traded company on the Tel Aviv Stock Exchange at the time).He is currently the Executive Vice President and Chief Financial Officer of ADAMA.
Aviram Lahav,男,1959年出生,拥有以色列国籍。他拥有学士学位(经济学和金融学学士学位,以及机械工程学位),并参加了哈佛商学院的高级管理课程(AMP)。Aviram Lahav是一名注册会计师。他曾担任MCA Inc.(菲亚特集团在以色列的授权经销商)的首席财务官,Europcar以色列子公司(一家汽车租赁公司)的首席执行官,Delta Galil Industries Ltd.的集团首席财务官,Delta Galil Industries Ltd.的美国子公司的首席执行官。他还担任Synergy Cables Ltd.(当时在特拉维夫证券交易所上市的一家上市公司)的首席执行官。他目前是ADAMA的执行副总裁兼首席财务官。
Aviram Lahav, male, born in 1959, holds Israeli nationality.He has a bachelor's degree (Bachelor of Economics and Finance, as well as a degree in Mechanical Engineering) and has participated in the Advanced Management Program (AMP) at Harvard Business School.Aviram Lahav is a certified public accountant.He has previously served as the Chief Financial Officer of MCA Inc., an authorized dealer of the Fiat Group in Israel, the Chief Executive Officer of Europcar's Israeli subsidiary (a car rental company),the Group Chief Financial Officer of Delta Galil Industries Ltd., the Chief Executive Officer of Delta Galil Industries Ltd.'s U.S.subsidiary, and the Chief Financial Officer and Chief Operating Officer of Delta Galil Industries Ltd.He also served as the Chief Executive Officer of Synergy Cables Ltd.(which was a publicly traded company on the Tel Aviv Stock Exchange at the time).He is currently the Executive Vice President and Chief Financial Officer of ADAMA.